PR Newswire (press release) On May 29, 2013, Actavis Inc. (Actavis) launched Zoledronic Acid Actavis 4mg/5ml concentrate for solution for infusion in 14 European markets. The product was first to market in Germany, Spain, Sweden, Romania and Austria on Friday, May 17, 2013 and ... and more »
Irish Medical Times The primary screening tool is FRAX, which assesses fracture risk. Age , sex, weight and height are among the risk factors and previous fractures are taken into account, as are family history, parental hip fractures, history of steroid use, smoking ...
Zenopa Actavis has announced the introduction of a generic Zoledronic Acid product in 14 European markets, including the UK. The drug is the off-label equivalent of the branded product Zometa from Novartis and is indicated for the prevention of skeletal ...
Renal and Urology News Of these, 233 received zoledronic acid and 57 received pamidronate; no patient received denosumab. The rate of skeletal-related events (SREs) was 6.4% in patients with BM compared with 1.4% in patients without BM. Among patients with BM, the SRE rate ...
The Lawyer (subscription) In a robust decision handed down by the English Court of Appeal, Novartis has been awarded an interim injunction against Hospira to prevent sales of generic zoledronic acid in the UK despite Novartis's patents having been declared invalid by the ...
BBC News The study, led by Professor Nick James at University Hospitals Birmingham NHS Foundation Trust, also found zoledronic acid halved the number of patients who suffered three or more fractures. 1427: Kathryn Hamlett BBC News Online. Did it! 8.5 miles in ... and more »
BBC News The study, led by Professor Nick James at University Hospitals Birmingham NHS Foundation Trust, also found zoledronic acid halved the number of patients who suffered three or more fractures. The findings were being presented at the American Society of ... and more »
Medscape Patients should receive zoledronic acid until disease progression, except those who have achieved a complete or very good partial response; there are no data indicating a survival advantage for zoledronic acid in these patients. There are no data ...
Cancer Network We're going to see the results of a randomized trial testing the combination of either strontium-89 (which is a radiopharmaceutical) or zoledronic acid (a...
4-traders (press release) Zoledronic Acid Actavis, the generic equivalent of the Zometa® brand product from Novartis, is indicated for the prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumor-induced ...
